Skip to main content
Galapagos NV logo

Galapagos NV — Investor Relations & Filings

Ticker · GLPG ISIN · BE0003818359 LEI · 549300QKJ78IY0IOV655 BR Manufacturing
Open in API
Filings indexed 2,865 across all filing types
Latest filing 2017-07-28 Regulatory Filings
Country BE Belgium
Listing BR GLPG

About Galapagos NV

https://www.glpg.com/

Galapagos NV is a biotechnology company focused on transforming patient outcomes through scientific innovation. The company is strategically concentrating its efforts on its cell therapy platform, which is engineered for the scalable, decentralized, and rapid production of next-generation treatments. A key feature of this platform is a median 7-day vein-to-vein delivery time. In parallel with this focus, Galapagos is actively seeking partners to take over its portfolio of small molecule assets, including its TYK2 inhibitor program for autoimmune indications. This strategic shift allows the company to prioritize the growth and development of its cell therapy pipeline through internal discovery, partnerships, and acquisitions.

Recent filings

Filing Released Lang Actions
Servier licenses GLPG1972 in osteoarthritis from Galapagos
Regulatory Filings Classification · 95% confidence The document is explicitly titled as a "Press release" and details a licensing agreement between two pharmaceutical companies (Servier and Galapagos) regarding a drug candidate (GLPG1972). It announces a specific corporate transaction (licensing/option exercise) and includes financial details (€6 million license fee, €290 million milestones) and forward-looking statements typical of such announcements. This type of announcement, which details corporate actions, partnerships, or significant business developments outside of routine financial reporting (like 10-K or ER), often falls under general regulatory announcements or specific transaction categories. Since there is no specific category for 'Licensing Agreement' or 'Corporate Transaction', and it is a formal announcement intended for the market, it is best classified as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if the focus was purely on the cash component, but the core is the business deal. Given the context of market-sensitive information dissemination, RNS is the most appropriate general regulatory fallback for non-standard reports.
2017-07-28 English
Solid financials support R&D progress
Earnings Release Classification · 95% confidence The document is an earnings release for Galapagos NV for the first half of 2017. It contains key financial highlights, management commentary, and a summary table of financial results. While it references a more detailed report available on their website, the document itself provides sufficient substantive financial data and analysis to qualify as an Earnings Release (ER) rather than a mere publication announcement. It is not a full interim report (IR) as it is a summary announcement of results. H1 2017
2017-07-28 English
Solid financials support R&D progress
Earnings Release Classification · 99% confidence The document explicitly states it announces the 'unaudited first half-year results' for the period ended 30 June 2017. It provides key financial highlights (Revenues, Operating loss, Cash position) and detailed comparative tables for the first half of the year. This content strongly aligns with the definition of an Interim / Quarterly Report (IR). Although it mentions the full H1 2017 report is available elsewhere, this document itself contains the core results announcement, making it an 'IR' rather than just an 'RPA' (Report Publication Announcement), especially given its substantial length (over 11,000 characters) which suggests it is more than just a brief notice. It is not a full Annual Report (10-K) as it covers only six months. H1 2017
2017-07-28 English
6-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, Galapagos NV. It includes a press release as Exhibit 99.1 dated July 27, 2017. The text indicates that the Form 6-K is used to furnish reports or documents that the issuer must make public under home country laws or exchange rules. The document is relatively short (2693 characters) and primarily serves to submit a press release rather than containing detailed financial data or a full report. According to the rules, such filings that provide a report or press release as an attachment or reference, without substantive financial statements or detailed report content, should be classified as Regulatory Filings (RNS).
2017-07-28 English
H1 Report ENG.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'H1 Report 2017' and contains comprehensive financial statements, management discussion and analysis, and an auditor's report for the first half of the fiscal year. It provides detailed financial data, including balance sheets and income statements for the period ending June 30, 2017. This fits the definition of an Interim/Quarterly Report (IR) as it is a comprehensive financial report for a period shorter than a full fiscal year. H1 2017
2017-07-27 English
H1 Report NL.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Halfjaarverslag 2017' (Half-Year Report 2017) for the Galapagos group. It contains comprehensive financial statements, management discussion and analysis (Brief van het management), operational highlights for the first half of 2017, and consolidated interim figures. It is a formal interim financial report covering a period shorter than a full fiscal year, containing substantive financial data and analysis, thus fitting the definition of an Interim/Quarterly Report (IR). H1 2017
2017-07-27 Dutch

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.